Acer Therapeutics (ACER) Revenue & Revenue Breakdown
Acer Therapeutics Revenue Highlights
Latest Revenue (Q)
$371.79K
Acer Therapeutics Revenue by Period
Acer Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $1.26M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $432.12K | -275.44% |
| 2017-12-31 | $-246.30K | -108.48% |
| 2016-12-31 | $2.91M | 13.65% |
| 2015-12-31 | $2.56M | 100.99% |
| 2014-12-31 | $1.27M | 0.42% |
| 2013-12-31 | $1.27M | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | -100.00% |
| 2007-12-31 | $46.45K | - |
| 2006-12-31 | $46.45K | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | -100.00% |
| 2003-09-30 | $3.92K | -75.61% |
| 2002-09-30 | $16.05K | -93.57% |
| 2001-09-30 | $249.56K | -69.43% |
| 2000-09-30 | $816.24K | -71.87% |
| 1999-09-30 | $2.90M | - |
Acer Therapeutics generated - in revenue during NA 2022, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Acer Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $371.79K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $360.00K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $4.00M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $432.12K | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $-246.30K | 100.00% |
| 2017-09-30 | - | -100.00% |
| 2017-06-30 | $-26.00 | -105.57% |
| 2017-03-31 | $467.00 | -99.94% |
| 2016-12-31 | $726.29K | 0.00% |
| 2016-09-30 | $726.29K | - |
| 2016-06-30 | $726.29K | - |
| 2016-03-31 | $726.29K | -0.00% |
| 2015-12-31 | $726.29K | 0.00% |
| 2015-09-30 | $726.29K | -0.00% |
| 2015-06-30 | $726.29K | 92.42% |
| 2015-03-31 | $377.45K | 22.67% |
| 2014-12-31 | $307.69K | - |
| 2014-09-30 | $307.69K | - |
| 2014-06-30 | $307.69K | -11.80% |
| 2014-03-31 | $348.84K | - |
| 2013-12-31 | $348.84K | - |
| 2013-09-30 | $348.84K | - |
| 2013-06-30 | $348.84K | 58.49% |
| 2013-03-31 | $220.10K | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Acer Therapeutics generated $371.79K in revenue during Q3 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Acer Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| YS | LakeShore Biopharma | $687.20M | $164.98M |
| SABS | SAB Biotherapeutics | $2.24M | $263.14K |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| LEXX | Lexaria Bioscience | $226.21K | $84.00K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
| REVB | Revelation Biosciences | - | - |
| HOTH | Hoth Therapeutics | - | - |
| ATXI | Avenue Therapeutics | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| ONCR | Oncorus | - | - |
| ACER | Acer Therapeutics | - | $371.79K |
| KTTA | Pasithea Therapeutics | - | - |
ACER Revenue FAQ
What is Acer Therapeutics’s yearly revenue?
Acer Therapeutics's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021. The company's yearly revenue for 2021 was $1.26M, representing an increase of 100.00% compared to 2020. ACER's yearly revenue for 2020 was $0, representing an increase of 100.00% compared to 2019.
What is Acer Therapeutics’s quarterly revenue?
Acer Therapeutics's quarterly revenue for Q3 2023 was $371.79K, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $0, a 100.00% increase from the previous quarter (Q1 2023), and a 0% increase year-over-year (Q2 2022). ACER's quarterly revenue for Q1 2023 was $0, a 100.00% increase from the previous quarter (Q4 2022), and a 0% increase year-over-year (Q1 2022).
What is Acer Therapeutics’s revenue growth rate?
Acer Therapeutics's revenue growth rate for the last 3 years (2020-2022) was 0%, and for the last 5 years (2018-2022) was -100.00%.